These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36710959)

  • 1. Quantitative proteomics and biological activity of extracellular vesicles engineered to express SARS-CoV-2 spike protein.
    Choi D; Khan N; Montermini L; Tawil N; Meehan B; Kim DK; Roth FP; Divangahi M; Rak J
    J Extracell Biol; 2022 Oct; 1(10):e58. PubMed ID: 36710959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered small extracellular vesicles displaying ACE2 variants on the surface protect against SARS-CoV-2 infection.
    Kim HK; Cho J; Kim E; Kim J; Yang JS; Kim KC; Lee JY; Shin Y; Palomera LF; Park J; Baek SH; Bae HG; Cho Y; Han J; Sul JH; Lee J; Park JH; Cho YW; Lee W; Jo DG
    J Extracell Vesicles; 2022 Jan; 11(1):e12179. PubMed ID: 34982509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Millisecond dynamic of SARS-CoV-2 spike and its interaction with ACE2 receptor and small extracellular vesicles.
    Lim K; Nishide G; Yoshida T; Watanabe-Nakayama T; Kobayashi A; Hazawa M; Hanayama R; Ando T; Wong RW
    J Extracell Vesicles; 2021 Dec; 10(14):e12170. PubMed ID: 34874124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID-19 Therapy.
    Xie F; Su P; Pan T; Zhou X; Li H; Huang H; Wang A; Wang F; Huang J; Yan H; Zeng L; Zhang L; Zhou F
    Adv Mater; 2021 Dec; 33(49):e2103471. PubMed ID: 34665481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proviral role of human respiratory epithelial cell-derived small extracellular vesicles in SARS-CoV-2 infection.
    Berry F; Morin-Dewaele M; Majidipur A; Jamet T; Bartier S; Ignjatovic E; Toniutti D; Gaspar Lopes J; Soyeux-Porte P; Maillé P; Saldana C; Brillet R; Ahnou N; Softic L; Couturaud B; Huet É; Ahmed-Belkacem A; Fourati S; Louis B; Coste A; Béquignon É; de la Taille A; Destouches D; Vacherot F; Pawlotsky JM; Firlej V; Bruscella P
    J Extracell Vesicles; 2022 Oct; 11(10):e12269. PubMed ID: 36271885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection.
    Fu Y; Xiong S
    J Control Release; 2021 Jul; 335():584-595. PubMed ID: 34089793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles.
    Wu C; Xu Q; Wang H; Tu B; Zeng J; Zhao P; Shi M; Qiu H; Huang Y
    Acta Pharm Sin B; 2022 Mar; 12(3):1523-1533. PubMed ID: 34522576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Spike-Extracellular Vesicles (S-EVs) as a Tool to Mimic SARS-CoV-2 Interaction with Host Cells.
    Verta R; Grange C; Skovronova R; Tanzi A; Peruzzi L; Deregibus MC; Camussi G; Bussolati B
    Cells; 2022 Jan; 11(1):. PubMed ID: 35011708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy.
    Inal JM
    Clin Sci (Lond); 2020 Jun; 134(12):1301-1304. PubMed ID: 32542396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice.
    Ogger PP; Martín MG; Jang S; Zhou J; Brown J; Sukhova K; Furnon W; Patel AH; Cowton V; Palmarini M; Barclay WS; Johansson C
    Front Immunol; 2024; 15():1383612. PubMed ID: 38742107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.
    Kazemi S; López-Muñoz AD; Hollý J; Jin L; Yewdell JW; Dolan BP
    J Virol; 2022 Sep; 96(17):e0025622. PubMed ID: 36000847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus.
    Yeh H; Vo DNK; Lin ZH; Ho HPT; Hua WJ; Qiu WL; Tsai MH; Lin TY
    Phytomedicine; 2022 Aug; 103():154215. PubMed ID: 35691077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2.
    Rowland R; Brandariz-Nuñez A
    Microbiol Spectr; 2021 Oct; 9(2):e0119921. PubMed ID: 34494876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
    Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
    Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus.
    Cocozza F; Névo N; Piovesana E; Lahaye X; Buchrieser J; Schwartz O; Manel N; Tkach M; Théry C; Martin-Jaular L
    J Extracell Vesicles; 2020 Dec; 10(2):e12050. PubMed ID: 33391636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein.
    Manangeeswaran M; Ireland DDC; Thacker SG; Lee HN; Kelley-Baker L; Lewkowicz AP; Rothlauf PW; Cornejo Pontelli M; Bloyet LM; Eckhaus MA; Mendoza MI; Whelan S; Verthelyi D
    Front Immunol; 2022; 13():919815. PubMed ID: 35967447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies.
    Troyer Z; Alhusaini N; Tabler CO; Sweet T; de Carvalho KIL; Schlatzer DM; Carias L; King CL; Matreyek K; Tilton JC
    J Extracell Vesicles; 2021 Jun; 10(8):e12112. PubMed ID: 34188786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2.
    El-Shennawy L; Hoffmann AD; Dashzeveg NK; McAndrews KM; Mehl PJ; Cornish D; Yu Z; Tokars VL; Nicolaescu V; Tomatsidou A; Mao C; Felicelli CJ; Tsai CF; Ostiguin C; Jia Y; Li L; Furlong K; Wysocki J; Luo X; Ruivo CF; Batlle D; Hope TJ; Shen Y; Chae YK; Zhang H; LeBleu VS; Shi T; Swaminathan S; Luo Y; Missiakas D; Randall GC; Demonbreun AR; Ison MG; Kalluri R; Fang D; Liu H
    Nat Commun; 2022 Jan; 13(1):405. PubMed ID: 35058437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages.
    Satta S; Meng Z; Hernandez R; Cavallero S; Zhou T; Hsiai TK; Zhou C
    Theranostics; 2022; 12(6):2639-2657. PubMed ID: 35401811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.